Literature DB >> 19464566

Exposure and toxicity of green tea polyphenols in fasted and non-fasted dogs.

I M Kapetanovic1, J A Crowell, R Krishnaraj, A Zakharov, M Lindeblad, A Lyubimov.   

Abstract

Standardized green tea extract was evaluated for exposure and toxicity in Beagle dogs following oral dosing by capsules. The main component (-)-epigallocatechin gallate (EGCG) accounted for 56-72% of the material. A 9-month chronic study (0, 200, 500, and 1000 mg/kg/day) was done in fasted dogs to take advantage of the reported improved catechin bioavailability with fasting. Extensive morbidity, mortality, and pathology of many major organs led to its early termination at 6.5 months and prevented identification of the toxicity mechanisms. A follow-up 13-week study examined the exposure to and toxicity of the extract. In general, toxicities were less severe than in the chronic study during the same interval. Dosing in a fed state resulted in considerably lower and less variable exposure than found under fasted conditions. Toxicity was less frequent and of lesser severity with lower exposure but limited sample size and large variability prevented reaching that definitive conclusion. Differences in mortality and morbidity between the preliminary terminated chronic and follow-up subchronic studies with the same dose of the same drug lot and similar exposure were not fully resolved as there may be other as yet unclear confounding factors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464566      PMCID: PMC2687403          DOI: 10.1016/j.tox.2009.03.007

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  35 in total

1.  Serious adverse liver reactions associated with herbal weight-loss supplements.

Authors:  E Bjornsson; Rolf Olsson
Journal:  J Hepatol       Date:  2007-05-29       Impact factor: 25.083

2.  Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.

Authors:  H-H Sherry Chow; Iman A Hakim; Donna R Vining; James A Crowell; James Ranger-Moore; Wade M Chew; Catherine A Celaya; Steven R Rodney; Yukihiko Hara; David S Alberts
Journal:  Clin Cancer Res       Date:  2005-06-15       Impact factor: 12.531

3.  Epigallocatechin gallate-induced histamine release in patients with green tea-induced asthma.

Authors:  T Shirai; A Sato; K Chida; H Hayakawa; J Akiyama; M Iwata; M Taniguchi; K Reshad; Y Hara
Journal:  Ann Allergy Asthma Immunol       Date:  1997-07       Impact factor: 6.347

4.  Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats.

Authors:  Yan Cai; Nathan D Anavy; H-H Sherry Chow
Journal:  Drug Metab Dispos       Date:  2002-11       Impact factor: 3.922

5.  The antifolate activity of tea catechins.

Authors:  Enma Navarro-Perán; Juan Cabezas-Herrera; Francisco García-Cánovas; Marcus C Durrant; Roger N F Thorneley; José Neptuno Rodríguez-López
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

6.  Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers.

Authors:  U Ullmann; J Haller; J D Decourt; J Girault; V Spitzer; P Weber
Journal:  Int J Vitam Nutr Res       Date:  2004-07       Impact factor: 1.784

Review 7.  A review of the health effects of green tea catechins in in vivo animal models.

Authors:  Vanessa Crespy; Gary Williamson
Journal:  J Nutr       Date:  2004-12       Impact factor: 4.798

8.  Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.

Authors:  H-H Sherry Chow; Yan Cai; Iman A Hakim; James A Crowell; Farah Shahi; Chris A Brooks; Robert T Dorr; Yukihiko Hara; David S Alberts
Journal:  Clin Cancer Res       Date:  2003-08-15       Impact factor: 12.531

9.  Green tea-induced asthma: relationship between immunological reactivity, specific and non-specific bronchial responsiveness.

Authors:  T Shirai; K Reshad; A Yoshitomi; K Chida; H Nakamura; M Taniguchi
Journal:  Clin Exp Allergy       Date:  2003-09       Impact factor: 5.018

Review 10.  Green tea: Health benefits as cancer preventive for humans.

Authors:  Hirota Fujiki
Journal:  Chem Rec       Date:  2005       Impact factor: 6.935

View more
  30 in total

1.  The impact of green tea polyphenols on development and reproduction in Drosophila melanogaster.

Authors:  Terry E Lopez; Hoang M Pham; Julia Barbour; Phillip Tran; Benjamin Van Nguyen; Sean P Hogan; Richelle L Homo; Volkan Coskun; Samuel E Schriner; Mahtab Jafari
Journal:  J Funct Foods       Date:  2016-01-01       Impact factor: 4.451

2.  Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.

Authors:  Nagi B Kumar; Julio Pow-Sang; Kathleen M Egan; Philippe E Spiess; Shohreh Dickinson; Raoul Salup; Mohamed Helal; Jerry McLarty; Christopher R Williams; Fred Schreiber; Howard L Parnes; Said Sebti; Aslam Kazi; Loveleen Kang; Gwen Quinn; Tiffany Smith; Binglin Yue; Karen Diaz; Ganna Chornokur; Theresa Crocker; Michael J Schell
Journal:  Cancer Prev Res (Phila)       Date:  2015-04-14

3.  Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer.

Authors:  Katherine D Crew; Powel Brown; Heather Greenlee; Therese B Bevers; Banu Arun; Clifford Hudis; Heather L McArthur; Jenny Chang; Mothaffar Rimawi; Lana Vornik; Terri L Cornelison; Antai Wang; Hanina Hibshoosh; Aqeel Ahmed; Mary Beth Terry; Regina M Santella; Scott M Lippman; Dawn L Hershman
Journal:  Cancer Prev Res (Phila)       Date:  2012-07-24

4.  Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies.

Authors:  Jesus Lovera; Alexander Ramos; Deidre Devier; Virginia Garrison; Blake Kovner; Tara Reza; Dennis Koop; William Rooney; Anne Foundas; Dennis Bourdette
Journal:  J Neurol Sci       Date:  2015-08-07       Impact factor: 3.181

5.  Potential role of the mitochondria as a target for the hepatotoxic effects of (-)-epigallocatechin-3-gallate in mice.

Authors:  Karma D James; Mary J Kennett; Joshua D Lambert
Journal:  Food Chem Toxicol       Date:  2017-11-22       Impact factor: 6.023

6.  Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice.

Authors:  Seung Joon Kim; Ernest Amankwah; Shahnjayla Connors; Hyun Y Park; Maria Rincon; Heather Cornnell; Ganna Chornokur; Arig Ibrahim Hashim; Junsung Choi; Ya-Yu Tsai; Robert W Engelman; Nagi Kumar; Jong Y Park
Journal:  Cancer Prev Res (Phila)       Date:  2014-02-05

7.  Safety Evaluation of Green Tea Polyphenols Consumption in Middle-aged Ovariectomized Rat Model.

Authors:  Chwan-Li Shen; Gordon Brackee; Xiao Song; Michael D Tomison; VelvetLee Finckbone; Kelly T Mitchell; Lili Tang; Ming-Chien Chyu; Dale M Dunn; Jia-Sheng Wang
Journal:  J Food Sci       Date:  2017-07-28       Impact factor: 3.167

Review 8.  Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.

Authors:  Min Ji Bak; Soumyasri Das Gupta; Joseph Wahler; Nanjoo Suh
Journal:  Semin Cancer Biol       Date:  2016-03-22       Impact factor: 15.707

9.  A combination cocktail improves spatial attention in a canine model of human aging and Alzheimer's disease.

Authors:  Elizabeth Head; Heather L Murphey; Amy L S Dowling; Katie L McCarty; Samuel R Bethel; Jonathan A Nitz; Melanie Pleiss; Jenna Vanrooyen; Mike Grossheim; Jeffery R Smiley; M Paul Murphy; Tina L Beckett; Dieter Pagani; Frederick Bresch; Curt Hendrix
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

10.  Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK(®) Weight Loss Products: Results from the DILIN Prospective Study.

Authors:  Elizabeth X Zheng; Simona Rossi; Robert J Fontana; Raj Vuppalanchi; Jay H Hoofnagle; Ikhlas Khan; Victor J Navarro
Journal:  Drug Saf       Date:  2016-08       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.